(Q44417476)

2 December 2017

Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis (English)

1 reference

2 December 2017

Intravenous Itraconazole followed by Oral Itraconazole for the Treatment of Amphotericin-B-Refractory Invasive Pulmonary Aspergillosis (English)

1 reference

27 December 2023

0 references

D. Caillot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714819

reference URL

27 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12714819

reference URL

27 December 2023

publication date

1 January 2003

1 reference

full work available at URL

2 December 2017

https://www.karger.com/Article/Pdf/69281

1 reference

27 December 2023

1 reference

2 December 2017

109

1 reference

2 December 2017

3

1 reference

2 December 2017

111-118

1 reference

The epidemiology and prevention of invasive aspergillosis

2 December 2017

1

1 reference

Invasive Aspergillosis as an Opportunistic Infection in Nonallografted Patients with Multiple Myeloma: A European Organization for Research and Treatment of Cancer

27 December 2023

2

1 reference

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

27 December 2023

3

1 reference

Severe and common side-effects of amphotericin B lipid complex (Abelcet)

27 December 2023

4

1 reference

Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy

27 December 2023

5

1 reference

Diagnosis of atypical cases of infectious mononucleosis

27 December 2023

6

1 reference

Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.

27 December 2023

7

1 reference

Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study

27 December 2023

8

1 reference

Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole

27 December 2023

9

1 reference

27 December 2023

Identifiers

DOI

10.1159/000069281

1 reference

2 December 2017

1 reference